Core Viewpoint - Huatai Medical (688617) has seen a stock price increase of 6.93% this week, closing at 390.0 yuan as of March 28, 2025, with a total market capitalization of 40.279 billion yuan [1] Company Announcements - Vice President Han Yonggui plans to reduce his holdings by no more than 30,000 shares, which represents 0.0309% of the company's total equity [1] - Han Yonggui currently holds 124,364 shares, accounting for 0.1281% of the total equity, and the reduction will occur through centralized bidding and block trading methods [1] - The reduction period for centralized bidding is within three months after the announcement, with a limit of 1% of the total equity over any 90 consecutive days, while block trading has a limit of 2% [1] - The reason for the reduction is personal funding needs, and it is stated that this plan complies with relevant laws and regulations, not significantly impacting the company's governance structure or ongoing operations [1]
每周股票复盘:惠泰医疗(688617)高管减持股份计划